Norgestimate and medroxyprogesterone acetate do not attenuate the atheroprotective effects of 17β-estradiol in ovariectomized, apolipoprotein E–deficient mice

This publication has 48 references indexed in Scilit:

• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
  New England Journal of Medicine, 2000
• Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease
  New England Journal of Medicine, 1996
• Regression of Atherosclerosis in Female Monkeys
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• In vivo regulation of low‐density lipoprotein receptors by estrogen differs at the post‐transcriptional level in rat and mouse
  European Journal of Biochemistry, 1993
• Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
  Preventive Medicine, 1991
• Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women
  Journal of Bone and Mineral Research, 1990
• Continuous oestrogen-progestogen treatment and serum lipoproteins in postmenopausal women
  BJOG: An International Journal of Obstetrics and Gynaecology, 1987
• A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart Disease
  New England Journal of Medicine, 1985
• Estrogenic regulation of body weight in the female rat
  Hormones and Behavior, 1976